Insider Transactions in Q2 2022 at Nutex Health, Inc. (NUTX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 20
2022
|
John J Waters Director |
BUY
Conversion of derivative security
|
Direct |
64,516
+30.61%
|
$64,516
$1.55 P/Share
|
|
May 10
2022
|
Thomas T. Vo Chief Executive Officer |
BUY
Bona fide gift
|
Direct |
21,429
+0.08%
|
-
|
|
May 09
2022
|
Cheryl Yvonne Grenas Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,280
+50.0%
|
$57,840
$3.89 P/Share
|
|
May 09
2022
|
Michael Lee Reed Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,208
+50.0%
|
$63,624
$3.89 P/Share
|
|
May 09
2022
|
John J Waters Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,851
+50.0%
|
$65,553
$3.89 P/Share
|
|
May 09
2022
|
Mitchell Creem Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,208
+50.0%
|
$63,624
$3.89 P/Share
|
|
May 05
2022
|
Warren Hosseinion President |
SELL
Bona fide gift
|
Direct |
102,888
-8.93%
|
-
|
|
Apr 02
2022
|
Lawrence Schimmel Chief Medical Information Off |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
9,799
+3.59%
|
$9,799
$1.55 P/Share
|
|
Apr 02
2022
|
Lawrence Schimmel Chief Medical Information Off |
BUY
Conversion of derivative security
|
Direct |
19,597
+7.17%
|
$19,597
$1.55 P/Share
|
|
Apr 01
2022
|
Thomas T. Vo Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
267,728,389
+50.0%
|
-
|
|
Apr 01
2022
|
Michael L. Chang Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
12,008,523
+50.0%
|
-
|
|
Apr 01
2022
|
Matthew Stephen Young Director |
BUY
Grant, award, or other acquisition
|
Indirect |
42,134,210
+50.0%
|
-
|